相关实验视频
Updated: Jun 6, 2025
11:53
Cecal Ligation Puncture Procedure
Published on: May 7, 2011
54.7K
败血症中的氨酸- ангиотензин- алдостерон系统及其与外源性 ангиотензин II 的临床调制
Matthieu Legrand1, Ashish K Khanna2, Marlies Ostermann3
1Department of Anesthesia and Perioperative Care, Division of Critical Care Medicine, University of California San Francisco, 521 Parnassus Avenue, San Francisco, CA, 94143, USA. Matthieu.Legrand@ucsf.edu.
Critical care (London, England)
|November 27, 2024
概括
败血症扰乱了氨酸- ангиотензин- алдостерон系统 (RAAS),影响器官衰竭. 专家们讨论了使用血管素II来治疗败血症,并提出了治疗指南,以指导未来的研究.
科学领域:
- 关键护理医学 关键护理医学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 氨酸- ангиотензин- алдостерон系统 (RAAS) 在败血症的早期显著失调.
- 这种RAAS失调有助于器官衰竭和性休克患者的不良结果.
研究的目的:
- 审查RAAS调制在败血症中的作用和影响.
- 讨论外源性血管激素II在败血症休克中的新兴治疗用途.
主要方法:
- 一个跨国,多学科的专家小组召开讨论RAAS在败血症.
- 专家小组审查了当前对RAAS病理生理学的理解.
主要成果:
- 专家共识确定了RAAS在败血症失调的关键方面.
- 建议为患者选择和使用外源性血管新生II的治疗策略提供指导.
结论:
- 了解RAAS调制对于治疗败血症至关重要.
- 外源性 ангиотензин II 呈现出潜在的治疗途径,需要进一步的研究和验证的临床指导方针.
相关概念视频
01:33Hormonal Regulation
33.0K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.0K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
493
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
493
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
479
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
479
01:17Hormonal Regulation of Blood Pressure
2.5K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.5K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
590
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
590